Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also referred to as COVID-19, was declared a pandemic by the World Health Organization in March 2020. The manifestations of COVID-19 are widely variable and range from asymptomatic infection to multi-organ failure and death. Like other viral illnesses, acute myocarditis and/or pericarditis has been reported to be associated with COVID-19 infection. The guidelines for the diagnosis of COVID-19 introduced the echocardiogram for diagnosis of carditis in these patients
Pourpose
In our study we investigated the incidences of myocarditis and/or pericarditis in a consecutive series of 1540 Athletes undergo to agonostic certification that performed echocardiogram, and subdivided the incidence of carditis depend on the period and the possible subtype of the covid (alpha,beta,gamma,delta,epsilon).
Methods
From march 2020 to october 2022 we enrolled in this epidemiological evaluation 1540 patients that was affected by COVID
Every patients was admitted to ambulatory of sport medicine of 2 Italian centres on the major islands to perform a return to play agonist certificate.
Overall, 69% males and 31%. females were enrolled with a mean age of 24.3 years (12-67 years).
None presented a risk factor of a cardiac disease.
Results
The incidence of Echocardiographic abnormality was 3,2% in our population
The kind and the incidence of alteration was showed in table 1, and consist in dilated cardiomiopathy (0,4%), regional cinetic dysfunction (0,4%), pericardial effusion (1,9%), aspecific alterations (0,2%).
Based on the period we evaluated the incidence of the echocardiographic alterations during the seasons and in corralation of variant of COVID . The results was showed in figure 1
CONCLUSIONS
Based on our evalution the incidence of echocardiographic findings in COVID was 3,2% in all period , with a progressive reduction long the time, from alpha variant to epsilon variant